STOCK TITAN

RenovaCare Inc. Provides Notice of Proposed Derivative Settlement to All Record Holders and Beneficial Owners of RenovaCare, Inc.

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Negative)
Tags

RenovaCare Inc. (OTC: RCAR) has announced a proposed settlement for a derivative action lawsuit. Under the settlement terms, defendant Rayat will cancel all debt owed to him by RenovaCare. The company has also agreed to ensure that when a new Board of Directors is formed, the majority of board members will be independent, having no material relationship with the company, executive team, or day-to-day operations.

The settlement hearing is scheduled for April 22, 2025, where the court will determine if the settlement is fair and reasonable, and consider approval of up to $350,000 in attorneys' fees. Shareholders as of February 5, 2025, who wish to object must file written notices by April 2, 2025.

RenovaCare Inc. (OTC: RCAR) ha annunciato un accordo proposto per una causa legale derivativa. Secondo i termini dell'accordo, il convenuto Rayat annullerà tutti i debiti a lui dovuti da RenovaCare. L'azienda ha anche concordato di garantire che, quando sarà formato un nuovo Consiglio di Amministrazione, la maggior parte dei membri del consiglio sarà indipendente, senza alcuna relazione materiale con l'azienda, il team esecutivo o le operazioni quotidiane.

L'udienza sull'accordo è programmata per il 22 aprile 2025, quando il tribunale stabilirà se l'accordo è equo e ragionevole e valuterà l'approvazione di fino a $350,000 in spese legali. Gli azionisti che al 5 febbraio 2025 desiderano presentare opposizione devono inviare avvisi scritti entro il 2 aprile 2025.

RenovaCare Inc. (OTC: RCAR) ha anunciado un acuerdo propuesto para una demanda derivativa. Según los términos del acuerdo, el demandado Rayat cancelará toda la deuda que RenovaCare le debe. La empresa también ha acordado garantizar que, cuando se forme un nuevo Consejo de Administración, la mayoría de los miembros del consejo serán independientes, sin ninguna relación material con la empresa, el equipo ejecutivo o las operaciones diarias.

La audiencia del acuerdo está programada para el 22 de abril de 2025, donde el tribunal determinará si el acuerdo es justo y razonable, y considerará la aprobación de hasta $350,000 en honorarios de abogados. Los accionistas a partir del 5 de febrero de 2025 que deseen objetar deben presentar avisos por escrito antes del 2 de abril de 2025.

레노바케어 주식회사 (OTC: RCAR)는 파생소송에 대한 제안된 합의안을 발표했습니다. 합의 조건에 따라 피고인 레야트는 레노바케어가 그에게 지고 있는 모든 부채를 취소할 것입니다. 회사는 또한 새로운 이사회가 구성될 때 이사회의 대다수 구성원이 독립적이며, 회사, 경영진 또는 일상 운영과의 실질적인 관계가 없도록 보장하기로 동의했습니다.

합의 청문회는 2025년 4월 22일로 예정되어 있으며, 법원은 합의가 공정하고 합리적인지 여부를 결정하고 최대 $350,000의 변호사 수임료 승인을 고려할 것입니다. 2025년 2월 5일 기준으로 반대 의사를 표명하고자 하는 주주들은 2025년 4월 2일 이전에 서면 통지를 제출해야 합니다.

RenovaCare Inc. (OTC: RCAR) a annoncé un accord proposé pour une action en justice dérivée. Selon les termes de l'accord, le défendeur Rayat annulera toutes les dettes que RenovaCare lui doit. L'entreprise a également convenu de s'assurer que, lorsque un nouveau conseil d'administration sera formé, la majorité des membres du conseil sera indépendante, n'ayant aucune relation matérielle avec l'entreprise, l'équipe exécutive ou les opérations quotidiennes.

L'audience sur l'accord est prévue pour le 22 avril 2025, où le tribunal déterminera si l'accord est juste et raisonnable, et considérera l'approbation de jusqu'à 350 000 $ en frais d'avocat. Les actionnaires au 5 février 2025 qui souhaitent s'opposer doivent soumettre des avis écrits avant le 2 avril 2025.

RenovaCare Inc. (OTC: RCAR) hat eine vorgeschlagene Einigung für eine derivative Klage bekannt gegeben. Gemäß den Bedingungen der Einigung wird der Beklagte Rayat alle Schulden, die RenovaCare ihm schuldet, erlassen. Das Unternehmen hat sich auch verpflichtet sicherzustellen, dass, wenn ein neuer Vorstand gebildet wird, die Mehrheit der Vorstandsmitglieder unabhängig sein wird und keine wesentlichen Beziehungen zum Unternehmen, zum Führungsteam oder zu den täglichen Abläufen hat.

Die Anhörung zur Einigung ist für den 22. April 2025 angesetzt, bei der das Gericht entscheiden wird, ob die Einigung fair und angemessen ist, und die Genehmigung von bis zu 350.000 $ an Anwaltsgebühren in Betracht ziehen wird. Aktionäre, die am 5. Februar 2025 Einwände erheben möchten, müssen bis zum 2. April 2025 schriftliche Mitteilungen einreichen.

Positive
  • Cancellation of all company debt owed to defendant Rayat
  • Implementation of stronger corporate governance through board independence requirements
Negative
  • Payment of up to $350,000 in attorneys' fees and expenses
  • Ongoing legal proceedings indicating corporate governance issues

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- RenovaCare Inc. (OTC: RCAR):

IN THE EIGHTH JUDICIAL DISTRICT COURT OF THE STATE OF NEVADA
IN AND FOR CLARK COUNTY

PETER RIGSBY, Derivatively on Behalf of RENOVACARE, INC.,

 

Plaintiff,

v.

 

HARMEL S. RAYAT, KAIYO NEDD, ALAN L. RUBINO, THOMAS BOLD, ROBERT W. COOK, STEPHEN YAN-KLASSEN, and KENNETH KIRKLAND,

 

Defendants,

 

-and-

 

RENOVACARE, INC., a Nevada Corporation,

 

Nominal Defendant.

 

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

)

Case No. A-22-850369-C

 

Dept. No. 16

 

 

 

 

 

 

 

 

 

 

 

NOTICE OF PROPOSED DERIVATIVE SETTLEMENT

TO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF
RENOVACARE, INC. ("RENOVACARE" OR THE "COMPANY")
COMMON STOCK AS OF FEBRUARY 5, 2025 (THE "RECORD DATE")

PLEASE TAKE NOTICE that the above-captioned consolidated derivative action (the "Nevada State Court Action") is being settled on the terms set forth in a Stipulation of Settlement, dated February 5, 2025 (the "Stipulation" or "Settlement").1 Under the terms of the Stipulation, as a part of the proposed Settlement, defendant Rayat shall extinguish any and all debt owed to him by RenovaCare by cancelling any and all debt instruments memorializing the debt. In addition, RenovaCare shall, if and when a Board of Directors is reconstituted, ensure that a majority of the board members (i) do not have a material relationship with the Company; (ii) are not a part of the Company's executive team; and (iii) are not involved in the day-to-day operations of the Company (the "Reform"). The cancellation of the debt and this Reform are designed to address the claims asserted in the Nevada State Court Action and related Derivative Actions2 and enhance RenovaCare's internal controls. RenovaCare and its Board acknowledged and agreed that Plaintiffs' efforts, including their efforts in investigating, preparing, commencing, and prosecuting the Derivative Actions, were a material cause for the cancellation of the debt and the implementation of the Reform, and both confer substantial benefits upon RenovaCare and its shareholders.

The full Board reviewed the derivative settlement parameters, and exercising its business judgment and mindful of its duties to stockholders, approved the Settlement.

IF YOU WERE A RECORD OR BENEFICIAL OWNER OF RENOVACARE COMMON STOCK AS OF FEBRUARY 5, 2025. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY AS YOUR RIGHTS MAY BE AFFECTED BY PROCEEDINGS IN THE ABOVE REFERENCED LITIGATION.

On April 22, 2025, at 9:30a.m., the Court will hold a hearing (the "Settlement Hearing") in the Nevada State Court Action, either in person, telephonically or via video. The purpose of the Settlement Hearing is to determine (i) whether the Settlement is fair, reasonable and adequate;

(ii) whether a final judgment should be entered and the Nevada State Court Action should be dismissed with prejudice pursuant to the Stipulation; and (iii) whether to approve up to $350,000 in attorneys' fees and expenses for Plaintiffs' Counsel; and (iv) such other matters as may be necessary or proper under the circumstances.

Any Current RenovaCare Shareholder that objects to the Settlement shall have a right to appear and to be heard at the Settlement Hearing, provided that he, she or it was a shareholder of record or beneficial owner as of February 5, 2025. Any Current RenovaCare Shareholder who satisfies this requirement may enter an appearance through counsel of such shareholder's own choosing and at such shareholder's own expense, or may appear on their own. However, no Current RenovaCare Shareholder shall be heard at the Settlement Hearing unless, no later than April 2, 2025, such shareholder has filed with the Court, a written notice of objection containing the following information:

  1. Your name, legal address, and telephone number;
  2. The case name and number (Rigsby v. Rayat, et al., Case No. A-22-850369-C)
  3. Proof of being a Current RenovaCare Shareholder as of the Record Date, February 5, 2025;
  4. The date(s) you acquired your RenovaCare shares;
  5. A statement of each objection being made;
  6. Notice of whether you intend to appear at the Settlement Hearing (you are not required to appear);
  7. Copies of any papers you intend to submit to the Court, along with the names of any witness(es) you intend to call to testify at the Settlement Hearing and the subject(s) of their testimony; and
  8. The identities of any cases, by name, court, and docket number, in which the objector or his, her, or its attorney has objected to a settlement in the last three years.

Only Current RenovaCare Shareholders who have filed and delivered valid and timely written notices of objection will be entitled to be heard at the Settlement Hearing unless the Court orders otherwise. If you wish to object to the proposed Settlement, you must file the written objection described above with the Court on or before April 2, 2025.

Any Current RenovaCare Shareholder as of February 5, 2025 who does not make his, her or its objection in the manner provided herein shall be deemed to have waived such objection and shall be forever foreclosed from making any objection to the fairness, reasonableness or adequacy of the Settlement as incorporated in the Stipulation and/or to the requested attorneys' fees and expenses to Plaintiffs' Counsel, unless otherwise ordered by the Court, but shall otherwise be bound by the Judgment to be entered and the releases to be given.

Inquiries may be made to Plaintiffs' Counsel: Stephen J. Oddo, Robbins LLP, 5060 Shoreham Place, Suite 300, San Diego, CA 92122, Telephone: (619) 525-3990, soddo@robbinsllp.com; John P. Aldrich, Aldrich Law Firm, Ltd., 7866 West Sahara Avenue, Las Vegas, NV 89117, Telephone: 702-583-6748, jaldrich@johnaldrichlawfirm.com.

PLEASE DO NOT CONTACT THE COURT REGARDING THIS NOTICE

1 This notice should be read in conjunction with, and is qualified in its entirety by reference to, the text of the Stipulation, which has been filed with the Eighth Judicial District Court of the State of Nevada in and for Clark County. All capitalized terms herein have the same meanings as set forth in the Stipulation. The Stipulation can also be accessed on the website of Robbins LLP, Plaintiff's Counsel, at https://robbinsllp.com/category/notices/.
2 "Derivative Actions" means collectively the derivative actions styled as Rigsby v. Rayat, et al., Case No. A-22-850369-C (the "Nevada State Court Action"); Medrano v. Rayat, et al., Case No. CV 2022-006382 (Ariz. Super. Ct.-Maricopa Cnty.) (the "Arizona State Derivative Action"); and In re RenovaCare Derivative Litigation, Case No. 2:21-cv-20569 (D.N.J.) (the "New Jersey Federal Derivative Action").

DATED: February 11, 2025

soddo@robbinsllp.com

jaldrich@johnaldrichlawfirm.com

Source: RenovaCare Inc.

FAQ

What are the key terms of RenovaCare's (RCAR) derivative settlement?

The settlement includes the cancellation of all debt owed to defendant Rayat and requires that future board members be independent without material relationships to the company.

When is the settlement hearing for RenovaCare (RCAR) scheduled?

The settlement hearing is scheduled for April 22, 2025, at 9:30 a.m.

How much are the attorney fees in the RCAR settlement?

The settlement includes up to $350,000 in attorneys' fees and expenses for Plaintiffs' Counsel.

What is the deadline for RCAR shareholders to object to the settlement?

Shareholders must file written objections by April 2, 2025.

What corporate governance changes will RCAR implement after the settlement?

RenovaCare will ensure that the majority of future board members are independent, not part of the executive team, and not involved in daily operations.

Renovacare

OTC:RCAR

RCAR Rankings

RCAR Latest News

RCAR Stock Data

8.73k
87.35M
Biotechnology
Healthcare
Link
United States
Scottsdale